Patents by Inventor Juergen Theodor STEFFGEN

Juergen Theodor STEFFGEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240317875
    Abstract: The present invention relates to anti-CD40 antibodies and therapeutic methods for using the same for treating and/or preventing autoimmune or inflammatory diseases.
    Type: Application
    Filed: February 27, 2024
    Publication date: September 26, 2024
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Fenglei HUANG, Meera RAMANUJAM, Juergen Theodor STEFFGEN, Yasuhiro TSUDA, Sudha VISVANATHAN
  • Publication number: 20240309105
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: December 18, 2023
    Publication date: September 19, 2024
    Applicant: Boehringer Ingelheim International GmbH
    Inventors: Juergen Theodor STEFFGEN, David P. JOSEPH, James HILBERT, Patanjali RAVVA
  • Publication number: 20220089759
    Abstract: The present invention relates to anti-CD40 antibodies and therapeutic methods for using the same for treating and/or preventing autoimmune or inflammatory diseases.
    Type: Application
    Filed: September 17, 2021
    Publication date: March 24, 2022
    Inventors: Fenglei HUANG, Meera RAMANUJAM, Juergen Theodor STEFFGEN, Yasuhiro TSUDA, Sudha VISVANATHAN
  • Publication number: 20210261678
    Abstract: The present invention relates to new humanized antagonistic anti-CD40 antibodies and therapeutic and diagnostic methods and compositions for using the same.
    Type: Application
    Filed: June 28, 2019
    Publication date: August 26, 2021
    Inventors: Juergen Theodor STEFFGEN, David P. JOSEPH, James HILBERT, Patanjali RAVVA